Portrait of Kyle Yang, MD

Kyle Yang, MD

Physical Medicine & Rehabilitation | Pain Medicine

Nexus Medical LegalIn collaboration with Nexus Medical Legal

Dr. Kyle Yang is double board-certified in PM&R and Pain Medicine. He is available for QME and IME evaluations through Nexus Medical Legal in Northern and Southern California.

He earned his medical degree at UC Davis, completed PM&R residency at the UCLA/VA Healthcare System, and completed an Interventional Spine Medicine fellowship at UCLA. His academic work includes teaching and fellowship leadership in interventional physiatry.

His clinical focus includes musculoskeletal and nerve conditions and non-operative, minimally invasive pain care. This background is relevant to attorneys examining spine-related symptoms, treatment history, and functional impact.

Credentials
Double board-certified | QME and IME
Clinical expertise
Interventional spine care · Nerve conditions · Non-operative treatment
Evaluation services
QME | IME
Geographic availability
Northern & Southern California
Curriculum vitae
Available on request

QME office locations

  • Van Nuys

    14126 Sherman Way, #9, Van Nuys, CA 91405

  • Fountain Valley

    9475 Heil Ave., Unit D, Fountain Valley, CA 92708

  • Garden Grove

    12901 Harbor Blvd., Ste. 6, Garden Grove, CA 92840

  • Sacramento

    2 Scripps Drive, Suite 105, Sacramento, CA 95825

  • Stockton

    1350 W. Robinhood Drive, #7, Stockton, CA 95207

  • Modesto

    1700 Standiford Avenue, Suite 350, Modesto, CA 95350

  • Long Beach

    3939 Atlantic Ave., Ste. 114, Long Beach, CA 90807

  • Lynwood

    11123 Long Beach Blvd., Lynwood, CA 90262

  • South Gate

    2809 Tweedy Blvd., South Gate, CA 90280

  • East Los Angeles

    5301 Whittier Blvd., Ste. Atrium 1, Los Angeles, CA 90022

Locations reflect the supplied Nexus roster. Office availability and appointment format are confirmed at scheduling.

Physician Request

Request type

Please do not submit confidential patient or case information. Sample reports are provided only when approved for distribution and de-identified.